Jiangsu Hengrui Medicine
600276.SS
#404
Rank
NZ$98.37 B
Marketcap
NZ$14.82
Share price
1.94%
Change (1 day)
36.05%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2025 (TTM): NZ$0.21

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is NZ$0.22. In 2024 the company made an earnings per share (EPS) of NZ$0.24 an increase over its 2023 EPS that were of NZ$0.17.

EPS history for Jiangsu Hengrui Medicine from 2000 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$0.21-11.94%
2024NZ$0.2442.43%
2023NZ$0.178.77%
2022NZ$0.15-20.62%
2021NZ$0.19-26.59%
2020NZ$0.2627.24%
2019NZ$0.2128.41%
2018NZ$0.1620.04%
2017NZ$0.1331.21%
2016NZ$0.1011.46%
2015NZ$0.0916036.27%
2014NZ$0.0672219.77%
2013NZ$0.0561218.05%
2012NZ$0.0475423.9%
2011NZ$0.0383726.9%
2010NZ$0.0302412.37%
2009NZ$0.0269156.6%
2008NZ$0.017189.18%
2007NZ$0.01574114.48%
2006NZ$0.00733964.83%
2005NZ$0.00445235.55%
2004NZ$0.00328529.73%
2003NZ$0.00253219.86%
2002NZ$0.002112-2.71%
2001NZ$0.0021711.02%
2000NZ$0.002149